Javascript must be enabled to continue!
Virological suppression rate and its predictors among HIV/AIDS patients on antiretroviral therapy before and during the COVID-19 pandemic in Ethiopia: Systematic review and meta-analysis
View through CrossRef
Abstract
Background
Achieving viral load suppression is crucial for the prevention of complications and deaths related to HIV infection. Ethiopia has embraced the worldwide 90-90-90 target, but there is no national representative information regarding virological suppression. Therefore, this review aims to determine the pooled virological suppression rate and identify the pooled effect of contributing factors of viral suppression for HIV-positive patients on antiretroviral therapy in Ethiopia.
Method
We systematically searched websites and databases, including online repositories, to obtain primary studies. We assessed the quality of the included articles using the Newcastle‒Ottawa Scale appraisal checklist by two reviewers. Publication bias was checked using Egger’s regression test, the heterogeneity of the studies was assessed using I2 statistics and Q statistics, and sensitivity analysis was performed to identify any outlier results in the included studies. The Der Simonian Laird random-effects model was used to estimate the overall proportion of viral suppression, and STATA 17 statistical software was used for all types of analysis.
Result
A total of 21 eligible articles were used for this quantitative synthesis. The overall pooled virological suppression was 71% (95% CI: 64%, 77%). The pooled effects of poor adherence to ART (AOR = 0.33; 95% CI: 0.28, 0.40), body mass index (18.5–24.9 kg/m2) (AOR = 1.8; 95% CI: 1.37, 2.36), disclosure AOR = 1.41; 95% CI: 1.05, 1.89), absence of opportunistic infection (AOR = 1.68; 95% CI: 1.43, 1.97), and high baseline viral load (AOR = 0.65; 95% CI: 0.52, 0.81) were identified as significant predictors of viral suppression.
Conclusion
The overall pooled percentage of virological suppression was low compared with the global target of viral suppression. Poor adherence, normal body mass index, disclosure, absence of opportunistic infection and high viral load were contributing factors of viral suppression in Ethiopia. Responsible stakeholders should maximize their effort to achieve the global target of virological suppression by addressing significant predictors.
Prospero registration number and google link: CRD42023434248.
Research Square Platform LLC
Title: Virological suppression rate and its predictors among HIV/AIDS patients on antiretroviral therapy before and during the COVID-19 pandemic in Ethiopia: Systematic review and meta-analysis
Description:
Abstract
Background
Achieving viral load suppression is crucial for the prevention of complications and deaths related to HIV infection.
Ethiopia has embraced the worldwide 90-90-90 target, but there is no national representative information regarding virological suppression.
Therefore, this review aims to determine the pooled virological suppression rate and identify the pooled effect of contributing factors of viral suppression for HIV-positive patients on antiretroviral therapy in Ethiopia.
Method
We systematically searched websites and databases, including online repositories, to obtain primary studies.
We assessed the quality of the included articles using the Newcastle‒Ottawa Scale appraisal checklist by two reviewers.
Publication bias was checked using Egger’s regression test, the heterogeneity of the studies was assessed using I2 statistics and Q statistics, and sensitivity analysis was performed to identify any outlier results in the included studies.
The Der Simonian Laird random-effects model was used to estimate the overall proportion of viral suppression, and STATA 17 statistical software was used for all types of analysis.
Result
A total of 21 eligible articles were used for this quantitative synthesis.
The overall pooled virological suppression was 71% (95% CI: 64%, 77%).
The pooled effects of poor adherence to ART (AOR = 0.
33; 95% CI: 0.
28, 0.
40), body mass index (18.
5–24.
9 kg/m2) (AOR = 1.
8; 95% CI: 1.
37, 2.
36), disclosure AOR = 1.
41; 95% CI: 1.
05, 1.
89), absence of opportunistic infection (AOR = 1.
68; 95% CI: 1.
43, 1.
97), and high baseline viral load (AOR = 0.
65; 95% CI: 0.
52, 0.
81) were identified as significant predictors of viral suppression.
Conclusion
The overall pooled percentage of virological suppression was low compared with the global target of viral suppression.
Poor adherence, normal body mass index, disclosure, absence of opportunistic infection and high viral load were contributing factors of viral suppression in Ethiopia.
Responsible stakeholders should maximize their effort to achieve the global target of virological suppression by addressing significant predictors.
Prospero registration number and google link: CRD42023434248.
Related Results
The Hidden Problem of Cross-Reactivity: Challenges in HIV Testing During the COVID-19 Era: A Systematic Review
The Hidden Problem of Cross-Reactivity: Challenges in HIV Testing During the COVID-19 Era: A Systematic Review
Abstract
Introduction
Human immunodeficiency virus (HIV) and Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV2) surface glycoproteins, including shared epitope motifs, sho...
Capítulo 6 – HIV-AIDS, como tratar, o que fazer e o que não fazer durante o tratamento?
Capítulo 6 – HIV-AIDS, como tratar, o que fazer e o que não fazer durante o tratamento?
A infecção pelo vírus do HIV pode ocorrer de diversas maneiras, tendo sua principal forma a via sexual por meio do sexo desprotegido. O vírus do HIV fica em um período de incubação...
Small Cell Lung Cancer and Tarlatamab: A Meta-Analysis of Clinical Trials
Small Cell Lung Cancer and Tarlatamab: A Meta-Analysis of Clinical Trials
Abstract
Introduction
Tarlatamab is a Delta-like ligand 3 (DLL3) -directed bispecific T-cell engager recently approved for use in patients with advanced small cell lung cancer (SCL...
Faktor Prediktor Kegagalan Virologis pada Pasien HIV yang Mendapat Terapi ARV Lini Pertama dengan Kepatuhan Berobat Baik
Faktor Prediktor Kegagalan Virologis pada Pasien HIV yang Mendapat Terapi ARV Lini Pertama dengan Kepatuhan Berobat Baik
Pendahuluan. Pada negara dengan keterbatasan sumber daya, pengukuran viral load (VL) sebagai prediktor efektivitas terapi antiretroviral (ARV) tidak selalu mudah untuk diakses oleh...
Evaluasi Terapi Antiretroviral Pasien HIV/AIDS
Evaluasi Terapi Antiretroviral Pasien HIV/AIDS
Pengobatan antiretroviral (ARV) bertujuan untuk menurunkan jumlah virus (viral load) serta menghambat perburukan infeksi oportunistik. Ketidakrasionalan terapi ARV akan menyebabkan...
Improved virological response to highly active antiretroviral therapy in HIV‐1‐infected patients carrying the CCR5 Δ32 deletion
Improved virological response to highly active antiretroviral therapy in HIV‐1‐infected patients carrying the CCR5 Δ32 deletion
BackgroundPatients heterozygous for the C‐C chemokine receptor 5 (CCR5) Δ32 deletion spontaneously progress less rapidly to AIDS and death than do wild‐type patients. We investigat...
Evaluating the Science to Inform the Physical Activity Guidelines for Americans Midcourse Report
Evaluating the Science to Inform the Physical Activity Guidelines for Americans Midcourse Report
Abstract
The Physical Activity Guidelines for Americans (Guidelines) advises older adults to be as active as possible. Yet, despite the well documented benefits of physical a...
The Impact of IL28B Gene Polymorphisms on Drug Responses
The Impact of IL28B Gene Polymorphisms on Drug Responses
To achieve high therapeutic efficacy in the patient, information on pharmacokinetics, pharmacodynamics, and pharmacogenetics is required. With the development of science and techno...

